Kyprolis

Recall | Medicines | 19/12/2016

The marketing authorization holder informed its supplied customers in a letter dated December 15, 2016, that the vials may have cracks in the glass. Therefore, the affected batch is being recalled as a precautionary measure. The company is not aware of any product complaints or adverse reaction reports in connection with this defect.

Name of the medicinal product Kyprolis 30 mg Pulver zur Herstellung einer Infusionslösung
Marketing authorisation number(s) EU/1/15/1060/003
Marketing authorisation holder AmgenEurope B.V.

Durchführung Rückruf:
Amgen GmbH
Batch number(s) 1074018A
Classification of the recall§
BASG reference number INS - 640.001 - 1943
Email

Further inquiry note